Snipping the thread of life. Antimuscarinic side effects of medications in the elderly
The DOI matches its OpenAlex record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Drugs with antimuscarinic activity are used for a wide variety of medical conditions. Unfortunately, side effects that develop as a result of muscarinic blockade are common and their frequency and clinical significance appear to increase with advanced age. Nevertheless, such drugs are frequently prescribed to elderly persons, particularly to those living in nursing homes. This review details the prevalence of antimuscarinic drug use in the elderly, the classes of drugs that exhibit antimuscarinic activity, organ-specific effects of muscarinic blockade, side effects identified in elderly individuals, and strategies to prevent or treat complications of antimuscarinic therapy, including recent advances in the development of drugs with selective activity for specific subclasses of muscarinic receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine
Sitaram, N., Weingartner, H., & Gillin, J. C. (1978) · Science · doi:10.1126/science.351808 · Cited by 524
Cited by
Carnahan, R. M., Lund, B. C., Perry, P. J., Pollock, B. G., & Culp, K. R. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006292126 · Cited by 664
Anticholinergic side-effects of drugs in elderly people
Mintzer, J., & Burns, A. (2000) · Journal of the Royal Society of Medicine · doi:10.1177/014107680009300903 · Cited by 322
The Problems of Anticholinergic Adverse Effects in Older Patients
Feinberg, M. (1993) · Drugs & Aging · doi:10.2165/00002512-199303040-00004 · Cited by 299
Cao, Y.-J., Mager, D., Simonsick, E., Hilmer, S., Ling, S., Windham, B., Crentsil, V, Yasar, S., Fried, L., & Abernethy, D. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100303 · Cited by 188
Anticholinergic Drugs and Physical Function Among Frail Elderly Population
Landi, F., Russo, A., Liperoti, R., Cesari, M., Barillaro, C., Pahor, M., Bernabei, R., & Onder, G. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100035 · Cited by 176
Anticholinergics: theoretical and clinical overview
Nishtala, P. S., Salahudeen, M. S., & Hilmer, S. N. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1165664 · Cited by 167
“[1–3] Cholinergic effects are caused by the binding of the neurotransmitter acetylcholine to the muscarinic receptors present in the central nervous system (CNS) and peripheral tissues.[1,4] Use of anticholinergic medicines is associated with decreased functional and cognitive performance, poorer quality of life, impa…”
BackgroundInfluentialKersten, H., Molden, E., Tolo, I. K., Skovlund, E., Engedal, K., & Wyller, T. B. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls176 · Cited by 131
Chatterjee, S., Bali, V., Carnahan, R. M., Johnson, M. L., Chen, H., & Aparasu, R. R. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.12.011 · Cited by 38
High-risk drugs in the elderly population
Demaagd, G. (1995) · Geriatric Nursing · doi:10.1016/s0197-4572(05)80161-2 · Cited by 9
Metadata
- Authors
- Peters, N. L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1989-11-01
- Volume
- 149
- Issue
- 11
- Pages
- 2414-2420
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W4249080812
- Cited by
- 82
- References
- 2
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.